PASADENA, Calif.--(BUSINESS WIRE)-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that preclinical data on ARO-INHBE, an investigational RNAi-based medicine for the treatment of ...

Form Health, a virtual obesity care provider, launched a new program on Tuesday to prevent the shift from overweight to obesity. Boston-based Form Health already offers an obesity program for ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Digbi Health, the leader in precision biology-based telehealth care for three of the top four healthcare costs - Obesity, T2D, and Digestive Health - announced ...

BOSTON--(BUSINESS WIRE)--Today, Form Health, the leading provider of science-based obesity care in the United States, announced a new program to prevent progression from overweight to obesity.

Obesity now affects more than one in five children in the United States, and while there are effective, recommended interventions, availability is limited for most children. In two new studies, Yale ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Clemson University has received $768,000 in funding from the Centers for Disease Control and Prevention to implement the first year of $3.8 million, five-year High Obesity Program in rural and ...

Rhythm Pharmaceuticals announced significant data regarding their treatments for acquired hypothalamic obesity during the Endocrine Society’s Annual Meeting. Presentations highlighted the promising ...

Paul L. Berns, Chief Executive Officer, stated that Neumora "prioritized obesity as the lead indication for NMRA-215, our highly brain-penetrant NLRP3 inhibitor." He outlined, "We expect to have up to ...